Printer Friendly
The Free Library
14,632,679 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Correction to Advanced Tissue Sciences S-3 Registration Release.


Business Editors & Health-Medical Writers

BIOWIRE2K

LA JOLLA, Calif.--(BW HealthWire)--Feb. 11, 2002

Advanced Tissue Sciences, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: ATIS ATIS - A Tools Integration Standard ) issued a correction to an earlier news release announcing the effectiveness of an S-3 Registration Statement covering 14,014,842 shares of its common stock.

The 5,104,163 shares held by Smith & Nephew SNATS SNATS Systems Network Architecture Transaction Service (IBM) , Inc. were acquired between January 1998 and September 2000.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 11, 2002
Words:63
Previous Article:Multimedia Available: Toshiba Appoints Scott J. Maccabe as Vice President and General Manager of the Storage Device Division.
Next Article:Spectrum Contact Services Strengthens Leadership Team; Company Appoints New Executives to Guide Growth.
Topics:



Related Articles
Cartilage grafts grown in lab dishes. (Brief Article)
INAMED Corp. and Advanced Tissue Sciences Announce Strategic Alliance; For Aesthetic and Reconstructive Products.
Advanced Tissue Sciences Corrects Financial Table Header Information; Six Months Ended Sted Year Ended.
Advanced Tissue Sciences Announces Collaboration With Medtronic, Inc. and $20 Million Investment by Medtronic Affiliate.
Advanced Tissue Sciences Completes Private Placement of Stock.
Advanced Tissue Sciences Announces Effectiveness of S-3 Registration.
ORTEC SUCCESSFULY DEFENDS EUROPEAN PATENT ON ORCEL.
Advanced Tissue Sciences Files Shelf Registration.
Advanced Tissue Sciences Announces Its Registration Statement on Form S-3 Has Been Declared Effective.
Cell mates. (Letters).(Letter to the Editor)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles